1-167094912-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001080426.3(STYXL2):c.63C>A(p.Asn21Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,612,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001080426.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STYXL2 | ENST00000361200.7 | c.63C>A | p.Asn21Lys | missense_variant | 2/6 | 5 | NM_001080426.3 | ENSP00000354483.2 | ||
STYXL2 | ENST00000271385.9 | c.63C>A | p.Asn21Lys | missense_variant | 2/6 | 1 | ENSP00000271385.5 | |||
STYXL2 | ENST00000443333.1 | c.63C>A | p.Asn21Lys | missense_variant | 1/5 | 5 | ENSP00000404874.1 | |||
GPA33 | ENST00000632571.1 | c.-281-21373G>T | intron_variant | 4 | ENSP00000488407.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152082Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000243 AC: 6AN: 246676Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133420
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1460416Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726332
GnomAD4 genome AF: 0.000125 AC: 19AN: 152082Hom.: 0 Cov.: 30 AF XY: 0.000108 AC XY: 8AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | The c.63C>A (p.N21K) alteration is located in exon 1 (coding exon 1) of the DUSP27 gene. This alteration results from a C to A substitution at nucleotide position 63, causing the asparagine (N) at amino acid position 21 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at